Invention Grant
- Patent Title: Glycine transporter inhibiting substances
- Patent Title (中): 甘氨酸转运蛋白抑制物质
-
Application No.: US13257258Application Date: 2010-03-19
-
Publication No.: US08623898B2Publication Date: 2014-01-07
- Inventor: Akito Yasuhara , Shuji Yamamoto , Hiroshi Ohta , Yoshihisa Shirasaki , Kazunari Sakagami , Masato Hayashi , Tsuyoshi Shibata , Youichi Shimazaki , Yuko Araki , Kumi Abe , Xiang-Min Sun
- Applicant: Akito Yasuhara , Shuji Yamamoto , Hiroshi Ohta , Yoshihisa Shirasaki , Kazunari Sakagami , Masato Hayashi , Tsuyoshi Shibata , Youichi Shimazaki , Yuko Araki , Kumi Abe , Xiang-Min Sun
- Applicant Address: JP Tokyo
- Assignee: Taisho Pharmaceutical Co., Ltd.
- Current Assignee: Taisho Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2009-067945 20090319
- International Application: PCT/JP2010/054831 WO 20100319
- International Announcement: WO2010/107115 WO 20100923
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D405/12 ; C07D409/12 ; C07D405/14 ; A01N43/64 ; A01N43/50 ; A61K31/41
Abstract:
The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsory disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.), depression, drug addiction, spasm, tremor, and sleep disorder:
Public/Granted literature
- US20120010414A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES Public/Granted day:2012-01-12
Information query
